APNHY
Price
$8.47
Change
-$0.35 (-3.96%)
Updated
Apr 3 closing price
Capitalization
4.83B
NXSCF
Price
$0.05
Change
-$0.02 (-28.57%)
Updated
Apr 1 closing price
Capitalization
82.26M
Ad is loading...

APNHY vs NXSCF

Header iconAPNHY vs NXSCF Comparison
Open Charts APNHY vs NXSCFBanner chart's image
Aspen Pharmacare Holdings
Price$8.47
Change-$0.35 (-3.96%)
Volume$557
Capitalization4.83B
NEXT SCIENCE
Price$0.05
Change-$0.02 (-28.57%)
Volume$4.5K
Capitalization82.26M
APNHY vs NXSCF Comparison Chart
Loading...
View a ticker or compare two or three
VS
APNHY vs. NXSCF commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APNHY is a Hold and NXSCF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (APNHY: $8.48 vs. NXSCF: $0.05)
Brand notoriety: APNHY and NXSCF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: APNHY: 80% vs. NXSCF: 46%
Market capitalization -- APNHY: $4.83B vs. NXSCF: $82.26M
APNHY [@Pharmaceuticals: Other] is valued at $4.83B. NXSCF’s [@Pharmaceuticals: Other] market capitalization is $82.26M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APNHY’s FA Score shows that 1 FA rating(s) are green whileNXSCF’s FA Score has 0 green FA rating(s).

  • APNHY’s FA Score: 1 green, 4 red.
  • NXSCF’s FA Score: 0 green, 5 red.
According to our system of comparison, APNHY is a better buy in the long-term than NXSCF.

Price Growth

APNHY (@Pharmaceuticals: Other) experienced а -7.73% price change this week, while NXSCF (@Pharmaceuticals: Other) price change was -28.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.90%. For the same industry, the average monthly price growth was -4.07%, and the average quarterly price growth was -12.01%.

Industries' Descriptions

@Pharmaceuticals: Other (-4.90% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
APNHY($4.83B) has a higher market cap than NXSCF($82.3M). APNHY YTD gains are higher at: 2.603 vs. NXSCF (-28.571). APNHY has higher annual earnings (EBITDA): 7.98B vs. NXSCF (-11.94M). APNHY has more cash in the bank: 8.05B vs. NXSCF (7.37M). NXSCF has less debt than APNHY: NXSCF (276K) vs APNHY (26.8B). APNHY has higher revenues than NXSCF: APNHY (38.4B) vs NXSCF (10.4M).
APNHYNXSCFAPNHY / NXSCF
Capitalization4.83B82.3M5,869%
EBITDA7.98B-11.94M-66,804%
Gain YTD2.603-28.571-9%
P/E Ratio14.73N/A-
Revenue38.4B10.4M369,231%
Total Cash8.05B7.37M109,188%
Total Debt26.8B276K9,710,145%
FUNDAMENTALS RATINGS
APNHY vs NXSCF: Fundamental Ratings
APNHY
NXSCF
OUTLOOK RATING
1..100
8031
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
51
Fair valued
PROFIT vs RISK RATING
1..100
75100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6294
P/E GROWTH RATING
1..100
63100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APNHY's Valuation (19) in the null industry is in the same range as NXSCF (51). This means that APNHY’s stock grew similarly to NXSCF’s over the last 12 months.

APNHY's Profit vs Risk Rating (75) in the null industry is in the same range as NXSCF (100). This means that APNHY’s stock grew similarly to NXSCF’s over the last 12 months.

NXSCF's SMR Rating (98) in the null industry is in the same range as APNHY (100). This means that NXSCF’s stock grew similarly to APNHY’s over the last 12 months.

APNHY's Price Growth Rating (62) in the null industry is in the same range as NXSCF (94). This means that APNHY’s stock grew similarly to NXSCF’s over the last 12 months.

APNHY's P/E Growth Rating (63) in the null industry is somewhat better than the same rating for NXSCF (100). This means that APNHY’s stock grew somewhat faster than NXSCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PKX45.14-1.61
-3.44%
POSCO Holdings
UNB28.30-1.82
-6.04%
Union Bankshares
IART20.06-1.72
-7.90%
Integra LifeSciences Holdings Corp
GDC2.15-0.26
-10.79%
GD Culture Group Limited
PGY9.65-1.46
-13.11%
Pagaya Technologies Ltd

APNHY and

Correlation & Price change

A.I.dvisor tells us that APNHY and TRUFF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APNHY and TRUFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APNHY
1D Price
Change %
APNHY100%
-4.02%
TRUFF - APNHY
21%
Poorly correlated
-6.78%
NXSCF - APNHY
20%
Poorly correlated
N/A
PRFX - APNHY
20%
Poorly correlated
-4.78%
ESALF - APNHY
20%
Poorly correlated
N/A
SDZNY - APNHY
20%
Poorly correlated
+0.68%
More

NXSCF and

Correlation & Price change

A.I.dvisor tells us that NXSCF and KMDA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NXSCF and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXSCF
1D Price
Change %
NXSCF100%
N/A
KMDA - NXSCF
27%
Poorly correlated
-6.41%
APNHY - NXSCF
20%
Poorly correlated
-4.02%
MVMDF - NXSCF
12%
Poorly correlated
N/A
OMID - NXSCF
6%
Poorly correlated
N/A
MRMD - NXSCF
5%
Poorly correlated
+6.43%
More